Business
Trevi Therapeutics Announces Additions to the Senior Leadership Team
Key Management Appointments Support Company Growth as Lead Trials Move Towards Data NEW HAVEN, Conn., Aug. 9, 2021 /PRNewswire/ -- Trevi Therapeutics, Inc.
About this update from Trevi Therapeutics, Inc.
[{"type":"text","content":"Key Management Appointments Support Company Growth as Lead Trials Move Towards Data\n\n\nNEW HAVEN, Conn., Aug. 9, 2021 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced the appointment of Lisa Delfini, CPA, as Chief Financial Officer and Danine Summers, as Vice President, Medical Affairs. Ms. Delfini will lead the accounting and finance operations. Ms. Summers will be responsible for educating the medical community on Haduvio's data and development programs through publications, congresses and relationship building with key opinion leaders. \n\n \n \n \n \n \n \n\n \nNew CFO and Vice President, Medical Affairs will be instrumental in Trevi's growth as lead trials move towards data\"We are thrilled to welcome Lisa and Danine to our skilled senior leadership team,\" said Jennifer L. Good, President and Chief Executive Officer of Trevi. \"Their knowledge and experience will be instrumental as we move towards enrollment completion and topline data in our Phase 2b/3 PRISM trial and Phase 2 CANAL trial and preparing for the next stage of growth at Trevi.\"\nMs. Delfini joins Trevi with 30 years of experience in the financial sector. Her background includes helping public and private companies with finance transformation and preparing for and executing capital raising activities, acquisitions, and other complex financial and accounting matters. As a Financial Accounting and Advisory Services Partner at Marcum LLP, Ms. Delfini led a team of professionals who provided advisory services on financial activities to companies. In this role, she served as interim CFO, CAO or controller for companies in multiple sectors, including pharmaceuticals. Previously, Ms. Delfini worked at General Electric where she was the Global Controller for the GE Corporate Technical Center of Excellence (TCOE) and then became the Global Controller for GE Industrial Solutions. Ms. Delfini began her career at Deloitte & Touche LLP where she worked for 16 years and completed her time there as a Client Service Partner. She holds a B.S. in Accounting from Lehigh University and is a Certified Public Accountant in the State of Connecticut. \nMs. Sum...